Overview

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Fol

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This is a bioequivalence trial to evaluate the bioequivalence of Myrin P Forte against reference drug in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Ethambutol
Isoniazid
Pyrazinamide
Rifampin